---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-017614"
form_type: "8-K"
ticker: "OGEN"
cik: "0001174940"
company_name: "ORAGENICS INC"
filed_at: "2022-06-23T23:59:59+00:00"
generated_at: "2026-06-24T23:33:01.048913+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Oragenics appoints Kimberly Murphy as President and CEO; base salary $430K, 800K options grant

## Summary
- Kimberly Murphy appointed President and CEO effective June 23, 2022; base salary $430,000, bonus target 50%, options for 800k shares at $0.295.
- Murphy was previously a board member since 2020; brings 25+ years vaccine industry experience from Merck and GSK.
- CFO Michael Sullivan awarded 250,000 stock options at $0.295 for interim PEO duties.
- Options vest over five tranches starting immediately through June 2024.

## SEC filing metadata
- accession: 0001493152-22-017614
- form_type: 8-K
- ticker: OGEN
- cik: 0001174940
- company_name: ORAGENICS INC
- filed_at: 2022-06-23T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1174940/000149315222017614/0001493152-22-017614-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1174940/000149315222017614/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-017614
- JSON: https://secwatch.observer/filing/0001493152-22-017614.json
- Plain text: https://secwatch.observer/filing/0001493152-22-017614.txt

## Key facts
- Executive change
  Kimberly Murphy was appointed as President and Chief Executive Officer at ORAGENICS INC.
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: On June 23, 2022, Oragenics Inc. (the “Company”) announced that the Board of Directors approved the appointment of Kimberly Murphy, as the Company’s new President and Chief Executive Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1174940/000149315222017614/0001493152-22-017614-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.